New PBS listing for CLL

Ibrutinib (Imbruvica) will soon be listed on the PBS for Australians with chronic lymphocytic leukaemia or small lymphocytic lymphoma, the government has announced. Patients who have relapsed or are refractory to at least one prior line of therapy and who are unsuitable for treatment with fludarabine will be able to access the subsidised treatment from ...

Already a member?

Login to keep reading.

© 2021 the limbic